40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-109.77%
Negative net income growth while CRK stands at 0.19%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
94.22%
D&A growth well above CRK's 48.57%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-154.57%
Negative yoy deferred tax while CRK stands at 1.76%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
26204.46%
Slight usage while CRK is negative at -233.31%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
410.20%
Well above CRK's 166.31%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
50.48%
Some CFO growth while CRK is negative at -5.02%. John Neff would note a short-term liquidity lead over the competitor.
-63.46%
Negative yoy CapEx while CRK is 13.87%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Acquisition spending well above CRK's 76.97%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-100.00%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
483.85%
Liquidation growth of 483.85% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
175.26%
We have some outflow growth while CRK is negative at -201.82%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-303.68%
We reduce yoy invests while CRK stands at 34.82%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
95.25%
Debt repayment growth of 95.25% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
3.88%
We slightly raise equity while CRK is negative at -25.81%. John Neff sees competitor possibly preserving share count or buying back shares.
1.88%
Buyback growth of 1.88% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.